Institute of Good Manufacturing Practices India

Global accredited training & certification provider

IGMPI Approvals & Accreditation : Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India, Approved Training Institute of Food Safety and Standards Authority of India (FSSAI), Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India, An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh, Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC)
Trusted by organizations & training participants in over 30 countries. Training | Certification | Education | Research

Roche, AbbVie become successful in Venclyxto Phase III results


05th June 2019

CLL trial data for Venclyxto (venetoclax) plus Gazyvaro (obinutuzumab) is shared by Roche and AbbVie in the New England Journal of Medicine. The trial was done in patients who had untreated chronic lymphocytic leukemia.

The primary endpoint for investigator-assessed progression-free survival was met during the pivotal phase III study. It was a fixed 12 month study, which depicts 65% reduction in chances of disease worsening or death in comparison to current treatment of Gazyvaro plus chlorambucil.

A median follow-up after 28 months depicts that the overall response rate of 84.7% was observed in patients who received chemotherapy-free combination. One year following the stopping treatment, about 88.2% patients remained progression-free in comparison to 64.1% during Gazyvaro plus chlorambucil arm treatment.

The outcomes obtained during CLL14 Phase III trials represent a major advancement to improvise the results during chronic lymphocytic leukaemia.


For further enquiries, write to or call us on:
info@igmpiindia.org/ +91 8587838177, +91 8130924488, 0120-2427175

Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR

Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like